PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test
2026-05-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
HEALEY ALS Platform Trial Regimen I expands to 240 participants
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies
2026-05-27T    Biotechnology   Health Care/Hospital   Publishing/Information Service 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer
2026-05-27T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Announcement of The Shaw Laureates 2026
2026-05-27T    Biotechnology   Computer/Electronics   Education   Health Care/Hospital 
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
2026-05-27T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved